To describe the prevalence and correlates of using conventional therapies, complementary and alternative therapies, or a combination of both types of therapies for menopausal symptoms and to examine the association between severity of symptoms and type of therapy use.
Data on 2,602 women aged 45 years or older were gathered through a cross-sectional telephone survey conducted in Florida, Minnesota, and Tennessee during 1997 and 1998 using the Behavioral Risk Factor Surveillance System. Participants were asked a series of questions about their menopausal status, menopausal symptoms, healthcare provider selection in relation to menopause, and therapies used for menopausal symptoms.
Of the eight menopausal symptoms assessed, the highest prevalence estimates were reported for hot flashes (62.9%), night sweats (48.3%), and trouble sleeping (41.1%). The average number of symptoms (range 0-8) was 3.10 (SD +/- 2.25) and, for women reporting symptoms, the average symptom severity score (range 1-24) was 6.78 (SD +/-4.63). About 45% of the women had not consulted with a healthcare provider for treatment of menopausal symptoms or for medical conditions related to menopause even though only 16.3% did not report any of the symptoms included in the survey. Forty-six percent of the women used complementary/alternative therapy either alone or in combination with conventional therapies. Age-adjusted average symptom severity scores were significantly higher among women who had undergone a hysterectomy, with removal of the ovaries (7.73; 95% CI 7.33,8.12) or without (7.60; 95% CI 7.16,8.05), than among women who experienced a natural menopause (6.42; 95% CI 6.14,6.71). Average severity scores were significantly higher among women who used both conventional and complementary/alternative therapies in relation to menopause (8.61; 95% CI 8.26,8.96) than among women who used only conventional therapies (7.09; 95% CI 6.67,7.50). This statistically significant association persisted when adjusted for age, education, income, race/ethnicity, state of residence, and menopausal category.
In this sample, 46% of the women used complementary/alternative therapy either alone or in combination with conventional therapies, whereas a third of the women did not use any therapy in relation to menopause. Although causal inferences cannot be made, the menopausal symptom severity score was significantly higher among women who reported using a combination of conventional and complementary/alternative therapies than among women who used only conventional therapy, only complementary/alternative, or no therapy.
"Also notable was a significantly higher use of dietary soy products (22.9% versus 6.5%; odds ratio, 6.23) in women with a history of breast cancer. A study examining the severity of menopausal symptoms and the use of both conventional and CAM therapies was conducted in 2602 women using the Behavioral Risk Factor Surveillance System . Approximately 46% of the women used CAM therapies. "
[Show abstract][Hide abstract] ABSTRACT: There is a great need for alternatives to hormone therapy for use by symptomatic menopausal women. Alternatives to estrogen can en-compass lifestyle change, complementary and alternative medicine (CAM), and prescription nonhormonal therapies. The use of CAM therapies for menopausal symptoms is widespread and has been increasing. In recent years, there has been an increase in the quantity and quality of research related to CAM therapy use for menopausal symptoms. A highly effective and safe CAM therapy for menopausal symptoms would be valuable but has remained elusive to date. This article reviews randomized controlled trials examining the efficacy of CAM therapies for menopausal symptoms.
Endocrinology & Metabolism Clinics of North America 01/2005; 33(4):717-39. DOI:10.1016/j.ecl.2004.07.004 · 3.40 Impact Factor
"Another Negeri study among teachers was, the prevalence of menopause among respondent was 21.9%, there was a high prevalence of skin dryness 44.2%, hot flushes 43.2%, fatigue 41%, irritability 35.8%, excessive sweating 34.7% among menopausal respondents (ZalkefLi and Sidik, 2003). Data on 2,602 women aged 45 years or older, the menopausal symptoms assessed, the highest prevalence estimates were reported for hot flashes (62.9%), night sweats (48.3%) and trouble sleeping (41.1%) (Keenan et al., 2003). By comparing the previous studies, the authors found that the prevalence of hot flushes and excessive sweating was the highest in Saudi females, but the prevalence of vaginal dryness was less than one in Negeri study and higher than the first one. "
[Show abstract][Hide abstract] ABSTRACT: Few researches dealt with the mean age and the correlation between menopause and osteoporosis in the Kingdom of Saudi Arabia (KSA). For this reason the authors have the idea to study severity of menopausal symptoms and knowledge, attitude and practice towards menopause among Saudi women. In this cross -sectional study, a sample of 233 Saudi women from 45 to 55 years old was collected randomly in Primary Care Clinic, King Khalid University Hospital, Riyadh. The data collection was in a form of questionnaire. The sample was categorized into 3 groups: premenopausal, perimenopausal and postmenopausal women. The severities of menopausal symptoms using menopause quality of life (MENQOL) questionnaire were as follows: Menopausal symptoms experienced by women in sample recorded that 68.51% suffered from hot flashes and excessive sweating, 37.7% dryness of vagina and 30.7% sexual problems. In assessing knowledge attitude and practices (KAP) towards menopause, 57.5% recognized that menopause was concerned with stop of menstruation and 47.9% denying the physical and psychological effects of menopause. Concerning the severity of symptoms, the hot flashes and excessive sweating was the most sever and frequent symptoms among three groups. And the authors needed more awareness towards menopause in Saudi community.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.